Ian Read may say goodbye to Pfizer, but he'll join the board at spinoff Viatris

18th December 2019 Uncategorised 0

With Pfizer’s Upjohn and Mylan’s marriage up for regulatory review, both drugmakers are working out the details on who’ll be tasked with leading the new generics giant. Turns out, one of the executives most responsible for securing the deal will now stay on to steer his newest creation. 

More: Ian Read may say goodbye to Pfizer, but he'll join the board at spinoff Viatris
Source: fierce